[1]
Rodríguez-Tanta, L.Y. et al. 2023. Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospital. Revista Peruana de Medicina Experimental y Salud Pública. 40, 1 (Mar. 2023), 16–24. DOI:https://doi.org/10.17843/rpmesp.2023.401.11563.